These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28192633)

  • 21. Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity.
    Byers PH
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):47S-52S. PubMed ID: 7963684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.
    Malfait F; Wenstrup RJ; De Paepe A
    Genet Med; 2010 Oct; 12(10):597-605. PubMed ID: 20847697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A family with Classical Ehlers-Danlos Syndrome (cEDS), mild bone fragility and without vascular complications, caused by the p.Arg312Cys mutation in COL1A1.
    Duong J; Rideout A; MacKay S; Beis J; Parkash S; Schwarze U; Horne SG; Vandersteen A
    Eur J Med Genet; 2020 Feb; 63(2):103730. PubMed ID: 31323331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ehlers-Danlos syndromes. Clinical, genetic and molecular aspects].
    Germain D
    Ann Dermatol Venereol; 1995; 122(4):187-204. PubMed ID: 8526413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics in classic Ehlers-Danlos syndrome.
    Malfait F; De Paepe A
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and molecular characteristics of 168 probands and 65 relatives with a clinical presentation of classical Ehlers-Danlos syndrome.
    Colman M; Syx D; De Wandele I; Dhooge T; Symoens S; Malfait F
    Hum Mutat; 2021 Oct; 42(10):1294-1306. PubMed ID: 34265140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Genetics and Pathogenesis of Ehlers-Danlos Syndrome and Related Connective Tissue Disorders.
    Ritelli M; Colombi M
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32414079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delineation of Ehlers-Danlos syndrome phenotype due to the c.934C>T, p.(Arg312Cys) mutation in COL1A1: Report on a three-generation family without cardiovascular events, and literature review.
    Colombi M; Dordoni C; Venturini M; Zanca A; Calzavara-Pinton P; Ritelli M
    Am J Med Genet A; 2017 Feb; 173(2):524-530. PubMed ID: 28102596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ehlers-Danlos syndrome, classical type: case management.
    Whitelaw SE
    Dermatol Nurs; 2004 Oct; 16(5):433-6, 449. PubMed ID: 15624708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ehlers-Danlos syndromes.
    Yeowell HN; Pinnell SR
    Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Two Independent
    Bauer A; Bateman JF; Lamandé SR; Hanssen E; Kirejczyk SGM; Yee M; Ramiche A; Jagannathan V; Welle M; Leeb T; Bateman FL
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31546637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of the 2017 criteria for vascular Ehlers-Danlos syndrome in 50 patients ascertained according to the Villefranche nosology.
    Ritelli M; Rovati C; Venturini M; Chiarelli N; Cinquina V; Castori M; Colombi M
    Clin Genet; 2020 Feb; 97(2):287-295. PubMed ID: 31600821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ehlers-Danlos syndrome presenting with primary nocturnal enuresis.
    Cunha M; Matias M; Marques I
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32024714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic outcomes for molecular genetic testing in children with suspected Ehlers-Danlos syndrome.
    Damseh N; Dupuis L; O'Connor C; Oh RY; Wang YW; Stavropoulos DJ; Schwartz SB; Mendoza-Londono R
    Am J Med Genet A; 2022 May; 188(5):1376-1383. PubMed ID: 35128800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
    Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
    Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A frameshift variant in the COL5A1 gene in a cat with Ehlers-Danlos syndrome.
    Spycher M; Bauer A; Jagannathan V; Frizzi M; De Lucia M; Leeb T
    Anim Genet; 2018 Dec; 49(6):641-644. PubMed ID: 30246406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
    Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
    Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome.
    Caley L; Campar A; Mendonça T; Farinha F
    Eur J Case Rep Intern Med; 2023; 10(2):003698. PubMed ID: 36970158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classic Ehlers-Danlos syndrome: case report and brief review of literature.
    Morais P; Ferreira O; Magina S; Silva C; Leão M; Maia A; Azevedo F
    Acta Dermatovenerol Croat; 2013; 21(2):118-22. PubMed ID: 24001420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.